Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide

Melissa Rayburg; Alexander Towbin; Hong Yin; Todd Maugans; Barry Maurer; Rajaram Nagarajan; Brian Weiss

doi:10.1002/pbc.22200

Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide

Melissa Rayburg, Alexander Towbin, Hong Yin, Todd Maugans, Barry Maurer, Rajaram Nagarajan, Brian Weiss

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.

Original language	English (US)
Pages (from-to)	1111-1113
Number of pages	3
Journal	Pediatric Blood and Cancer
Volume	53
Issue number	6
DOIs	https://doi.org/10.1002/pbc.22200
State	Published - 2009
Externally published	Yes

Keywords

Fenretinide
LCH
Neuroblastoma
New agents
Pediatric oncology

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.22200

Cite this

@article{0ba6e33ac9764706ba07df8b7911faee,

title = "Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide",

abstract = "Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.",

keywords = "Fenretinide, LCH, Neuroblastoma, New agents, Pediatric oncology",

author = "Melissa Rayburg and Alexander Towbin and Hong Yin and Todd Maugans and Barry Maurer and Rajaram Nagarajan and Brian Weiss",

year = "2009",

doi = "10.1002/pbc.22200",

language = "English (US)",

volume = "53",

pages = "1111--1113",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "6",

}

TY - JOUR

T1 - Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide

AU - Rayburg, Melissa

AU - Towbin, Alexander

AU - Yin, Hong

AU - Maugans, Todd

AU - Maurer, Barry

AU - Nagarajan, Rajaram

AU - Weiss, Brian

PY - 2009

Y1 - 2009

N2 - Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.

AB - Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.

KW - Fenretinide

KW - LCH

KW - Neuroblastoma

KW - New agents

KW - Pediatric oncology

UR - http://www.scopus.com/inward/record.url?scp=71049124468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71049124468&partnerID=8YFLogxK

U2 - 10.1002/pbc.22200

DO - 10.1002/pbc.22200

M3 - Article

C2 - 19621427

AN - SCOPUS:71049124468

SN - 1545-5009

VL - 53

SP - 1111

EP - 1113

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 6

ER -

Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this